Cite
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
MLA
Matsushita, Takashi, et al. “BAFF Inhibition Attenuates Fibrosis in Scleroderma by Modulating the Regulatory and Effector B Cell Balance.” Science Advances, vol. 4, no. 7, July 2018, p. eaas9944. EBSCOhost, https://doi.org/10.1126/sciadv.aas9944.
APA
Matsushita, T., Kobayashi, T., Mizumaki, K., Kano, M., Sawada, T., Tennichi, M., Okamura, A., Hamaguchi, Y., Iwakura, Y., Hasegawa, M., Fujimoto, M., & Takehara, K. (2018). BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance. Science Advances, 4(7), eaas9944. https://doi.org/10.1126/sciadv.aas9944
Chicago
Matsushita, Takashi, Tadahiro Kobayashi, Kie Mizumaki, Miyu Kano, Tomoyo Sawada, Momoko Tennichi, Ai Okamura, et al. 2018. “BAFF Inhibition Attenuates Fibrosis in Scleroderma by Modulating the Regulatory and Effector B Cell Balance.” Science Advances 4 (7): eaas9944. doi:10.1126/sciadv.aas9944.